The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
00
Industry Panel: Overcoming the Biggest Challenges in C+G/ATMPs
Industry Panel: Overcoming the Biggest Challenges in C+G/ATMPs |
Over the last few years, there has been enormous growth in the ATMP market, largely in part to world-class research institutions, an abundance of life science talent, a remarkable transportation infrastructure including cold chain supply, immense square footage of lab space, and world-class hospital systems. However, none of these moving parts could be possible without life science companies realizing their “aha moment” that collaboration and innovation were necessary to achieve the end goal – to lead the world in delivering therapies to patients. Experts from leading life sciences companies will discuss the importance of collaboration to overcome current issues facing the industry, specifically, talent, know-how, equipment, consumables necessary to run GMP processes, and access to development and manufacturing capacity. Please join us for this lively panel discussion centered around trends and challenges facing the overall ATMP industry and the novel strategies that each company is implementing to overcome these obstacles.
Speaker(s):
Richard
Denk,
Senior Consultant Aseptic Processing & Containment,
SKAN AG
Mr. Alexander
Haig,
Vice President, Operations,
INCOG BioPharma Services, Inc.